226 related articles for article (PubMed ID: 33752411)
1. High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.
Bender L; Somme F; Lhermitte B; Ahle G; Boone M; Blonski M; Pouget C; Truc G; Cebula H; Noël G
Chin Clin Oncol; 2021 Jun; 10(3):26. PubMed ID: 33752411
[TBL] [Abstract][Full Text] [Related]
2. Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series.
Pessina F; Navarria P; Clerici E; Soffietti R; Nibali MC; Rudà R; Riva M; Scorsetti M; Bello L
World Neurosurg; 2019 Mar; 123():e273-e279. PubMed ID: 30496926
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
4. Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.
Masalha W; Heiland DH; Franco P; Delev D; Haaker JG; Schnell O; Scheiwe C; Grauvogel J
J Neurooncol; 2018 Jan; 136(1):147-154. PubMed ID: 29081038
[TBL] [Abstract][Full Text] [Related]
5. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
7. World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.
Champeaux C; Jecko V
Neurochirurgie; 2016 Aug; 62(4):203-8. PubMed ID: 27339832
[TBL] [Abstract][Full Text] [Related]
8. Atypical meningioma. A study on recurrence and disease-specific survival.
Champeaux C; Houston D; Dunn L
Neurochirurgie; 2017 Sep; 63(4):273-281. PubMed ID: 28882609
[TBL] [Abstract][Full Text] [Related]
9. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
10. Survival and Prognostic Predictors of Anaplastic Meningiomas.
Masalha W; Heiland DH; Delev D; Fennell JT; Franco P; Scheiwe C; Mercas BI; Mader I; Schnell O; Grauvogel J
World Neurosurg; 2019 Nov; 131():e321-e328. PubMed ID: 31356972
[TBL] [Abstract][Full Text] [Related]
11. Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence.
Zhang H; Ma L; Wang YB; Shu C; Kuang W; Huang YA; Dong LQ; Cheng GG
World Neurosurg; 2017 Jan; 97():693-700.e11. PubMed ID: 27744084
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection.
Ren L; Cheng H; Chen J; Deng J; Wang D; Xie Q; Wakimoto H; Hua L; Gong Y
J Neurosurg; 2023 Jul; 139(1):49-58. PubMed ID: 36334291
[TBL] [Abstract][Full Text] [Related]
13. World Health Organization Grade II Meningioma: A 10-Year Retrospective Study for Recurrence and Prognostic Factor Assessment.
Champeaux C; Dunn L
World Neurosurg; 2016 May; 89():180-6. PubMed ID: 26850975
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
[TBL] [Abstract][Full Text] [Related]
15. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
[TBL] [Abstract][Full Text] [Related]
16. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features, Treatment, and Prognostic Factors of 56 Intracranial and Intraspinal Clear Cell Meningiomas.
Tao X; Dong J; Hou Z; Hao S; Zhang J; Wu Z; Liu B
World Neurosurg; 2018 Mar; 111():e880-e887. PubMed ID: 29325940
[TBL] [Abstract][Full Text] [Related]
18. Survival impacts of extent of resection and adjuvant radiotherapy for the modern management of high-grade meningiomas.
Li D; Jiang P; Xu S; Li C; Xi S; Zhang J; Chen Y; Jiang X; Zhang X; Sai K; Wang J; Mou Y; Ke C; Chen Z
J Neurooncol; 2019 Oct; 145(1):125-134. PubMed ID: 31493161
[TBL] [Abstract][Full Text] [Related]
19. World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
Zhang GJ; Zhang GB; Zhang YS; Li H; Li CB; Zhang LW; Li D; Wu Z; Zhang JT
World Neurosurg; 2018 Apr; 112():e754-e762. PubMed ID: 29382616
[TBL] [Abstract][Full Text] [Related]
20. World Health Organization Grade II Meningiomas: The Role of Adjuvant/Salvage Gamma Knife Surgery After Initial Surgery and Prognostic Factor Assessment.
Liu X; Shan B; Wang M; Xu J
World Neurosurg; 2018 Jan; 109():e352-e362. PubMed ID: 28987849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]